Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Delphine Casabonne, Yolanda Benavente, Julia Seifert, Laura Costas, Maria Armesto, Maria Arestin, Caroline Besson, Fatemeh S. Hosnijeh, Eric J. Duell, Elisabete Weiderpass, Giovanna Masala, Rudolf Kaaks, Federico Canzian, Maria-Dolores Chirlaque, Vittorio Perduca, Francesca R. Mancini, Valeria Pala, Antonia Trichopoulou, Anna Karakatsani, Carlo La VecchiaMaria-Jose Sanchez, Rosario Tumino, Marc J. Gunter, Pilar Amiano, Salvatore Panico, Carlotta Sacerdote, Julie A. Schmidt, Heiner Boeing, Matthias B. Schulze, Aurelio Barricarte, Elio Riboli, Anja Olsen, Anne Tjønneland, Roel Vermeulen, Alexandra Nieters, Charles H. Lawrie, Silvia de Sanjose

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

28 Citationer (Scopus)
4 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftInternational Journal of Cancer
Vol/bind147
Udgave nummer5
Sider (fra-til)1315-1324
Antal sider10
ISSN0020-7136
DOI
StatusUdgivet - 2020

Citationsformater